The price of Health Catalyst Inc (NASDAQ:HCAT) shares last traded on Wall Street fell -0.14% to $3.65.
HCAT stock price is now -10.99% away from the 50-day moving average and -42.23% away from the 200-day moving average. The market capitalization of the company currently stands at $254.04M.
On January 08, 2025, KeyBanc Capital Markets Upgraded its previous ‘Sector Weight’ rating to ‘Overweight’ on the stock keeping its target price maintained at $9, while ‘Evercore ISI’ rates the stock as ‘Outperform’
In other news, LeSueur Daniel, Chief Operating Officer sold 5,209 shares of the company’s stock on May 05 ’25. The stock was sold for $21,331 at an average price of $4.10. Upon completion of the transaction, the Chief Operating Officer now directly owns 205,832 shares in the company, valued at $0.75 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 03 ’25, Chief Operating Officer LeSueur Daniel sold 5,209 shares of the business’s stock. A total of $21,604 was realized by selling the stock at an average price of $4.15. This leaves the insider owning 211,041 shares of the company worth $0.77 million. A total of 4.85% of the company’s stock is owned by insiders.
During the past 12 months, Health Catalyst Inc has had a low of $3.56 and a high of $9.24. As of last week, the company has a debt-to-equity ratio of 1.07, a current ratio of 1.24, and a quick ratio of 1.24. The fifty day moving average price for HCAT is $4.1005 and a two-hundred day moving average price translates $6.317675 for the stock.
The latest earnings results from Health Catalyst Inc (NASDAQ: HCAT) was released for 2025-03-31. The net profit margin was -23.34% and return on equity was -19.80% for HCAT. The company reported revenue of $79.41 million for the quarter, compared to $74.72 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.28 percent.
